Respiratory Syncytial Virus (RSV)

  • CDC Offers Tips on Protecting Children Against Respiratory Syncytial Virus
    Respiratory syncytial virus (RSV) is common during fall, winter and spring. It usually causes mild, cold-like symptoms. But RSV can be serious, especially for infants and older adults. Help protect your child and others from RSV. RSV, is a common virus. It spreads through ...More
    2 weeks ago Posted in News
  • New Research Shows Fewer Deaths Related to RSV Than Previously Thought
    It's a virus that has long been characterized as dangerous and even deadly, but new research shows infant deaths from respiratory syncytial virus (RSV) are actually quite uncommon in the 21st century. Researchers at the University of Utah have shown there are approximately ...More
    2 weeks ago Posted in News
  • New Perspectives for Development of an RSV Vaccine
    Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus ...More
    October 16, 2014 Posted in News
  • A New Breakthrough in RSV Research
    The New England Journal of Medicine published research results today from a clinical trial of a drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with respiratory syncytial virus (RSV). Le Bonheur ...More
    August 28, 2014 Posted in News
  • Breakthrough in RSV Research to Help Infected Children
    Researchers at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center announced results from a clinical trial of a drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with ...More
    May 26, 2014 Posted in News
  • Researcher Receives $2.83 Million Grant to Develop Drugs for Prevention, Treatment of RSV Infection
    Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory Syncytial Virus (RSV) infection. The grant from the Eunice ...More
    April 25, 2014 Posted in News
  • Ginseng Can Treat and Prevent Influenza and RSV
    Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research findings by a scientist in Georgia State University's new Institute for Biomedical Sciences. In a ...More
    April 21, 2014 Posted in News
  • Researchers Find Genetic Trigger for RSV-Induced Infant Hospitalizations
    Researchers at UNC School of Medicine have pinpointed a viral protein that plays a major role in making respiratory syncytial virus (RSV) the most common cause of hospitalization in children under 1 year of age. The discovery, published April 8 in the Journal of ...More
    April 8, 2014 Posted in News
  • Scripps Research Institute Scientists Create Potential Vaccine Ingredient for RSV
    Scientists at the Scripps Research Institute (TSRI) have invented a new method for designing artificial proteins, and have used it to make key ingredients for a candidate vaccine against a dangerous virus, respiratory syncytial virus (RSV), a significant cause of infant ...More
    February 5, 2014 Posted in News
  • Imaging Technology Could Unlock Mysteries of RSV
    By the time they're 2 years old, most children have had respiratory syncytial virus (RSV) and suffered symptoms no worse than a bad cold. But for some children, especially premature babies and those with underlying health conditions, RSV can lead to pneumonia and bronchitis ...More
    January 2, 2014 Posted in News
« Previous123Next »